Shanghai Kinetic Medical Co., Ltd (300326.SZ)
CNY 6.83
(1.19%)
CNY 6.83
(1.19%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 235.76 Million CNY | -68.08% |
| 2022 | 107.22 Million CNY | -19.07% |
| 2021 | 318.78 Million CNY | 76.81% |
| 2020 | -17.48 Million CNY | -22.68% |
| 2019 | 428.67 Million CNY | -20.04% |
| 2018 | 561.98 Million CNY | 90.83% |
| 2017 | 264.17 Million CNY | 18.7% |
| 2016 | 221.46 Million CNY | 12.29% |
| 2015 | 209.4 Million CNY | 142.1% |
| 2014 | 85.87 Million CNY | 15.01% |
| 2013 | 71.78 Million CNY | 23.27% |
| 2012 | 64.69 Million CNY | 23.61% |
| 2011 | 49.47 Million CNY | 24.03% |
| 2010 | 40.67 Million CNY | 103.0% |
| 2009 | 20.5 Million CNY | 77.52% |
| 2008 | 11.58 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 20.33 Million CNY | 848.89% |
| 2024 Q2 | 46.75 Million CNY | 65.48% |
| 2024 Q3 | 38.19 Million CNY | -27.83% |
| 2023 Q1 | 86.05 Million CNY | 863.67% |
| 2023 Q2 | 39.4 Million CNY | -54.2% |
| 2023 Q3 | 27.01 Million CNY | -31.46% |
| 2023 FY | - CNY | -68.08% |
| 2023 Q4 | -4.27 Million CNY | -115.81% |
| 2022 Q4 | -11.26 Million CNY | -112.79% |
| 2022 FY | - CNY | -19.07% |
| 2022 Q3 | 88.09 Million CNY | 37.96% |
| 2022 Q1 | 91.66 Million CNY | -36.75% |
| 2022 Q2 | 63.85 Million CNY | -30.34% |
| 2021 Q1 | 65.92 Million CNY | 3.74% |
| 2021 FY | - CNY | 76.81% |
| 2021 Q2 | 77.06 Million CNY | 16.89% |
| 2021 Q4 | 144.92 Million CNY | 27.67% |
| 2021 Q3 | 113.51 Million CNY | 47.31% |
| 2020 Q2 | 78.96 Million CNY | 22.69% |
| 2020 Q1 | 64.36 Million CNY | -45.06% |
| 2020 Q4 | 63.54 Million CNY | -39.78% |
| 2020 Q3 | 105.52 Million CNY | 33.64% |
| 2020 FY | - CNY | -22.68% |
| 2019 Q2 | 99.24 Million CNY | -5.59% |
| 2019 FY | - CNY | -20.04% |
| 2019 Q3 | 94.64 Million CNY | -4.63% |
| 2019 Q1 | 105.11 Million CNY | -65.83% |
| 2019 Q4 | 117.15 Million CNY | 23.78% |
| 2018 Q1 | 71.46 Million CNY | 92.12% |
| 2018 Q4 | 307.64 Million CNY | 353.57% |
| 2018 Q3 | 67.82 Million CNY | -11.56% |
| 2018 Q2 | 76.69 Million CNY | 7.33% |
| 2018 FY | - CNY | 90.83% |
| 2017 Q1 | 55.72 Million CNY | 18.37% |
| 2017 FY | - CNY | 18.7% |
| 2017 Q2 | 83.11 Million CNY | 49.15% |
| 2017 Q4 | 37.19 Million CNY | -49.43% |
| 2017 Q3 | 73.55 Million CNY | -11.5% |
| 2016 FY | - CNY | 12.29% |
| 2016 Q1 | 38.06 Million CNY | -39.07% |
| 2016 Q2 | 64.95 Million CNY | 70.65% |
| 2016 Q3 | 67.19 Million CNY | 3.46% |
| 2016 Q4 | 47.07 Million CNY | -29.94% |
| 2015 Q3 | 53.24 Million CNY | -30.06% |
| 2015 Q4 | 62.47 Million CNY | 17.34% |
| 2015 FY | - CNY | 142.1% |
| 2015 Q2 | 76.12 Million CNY | 140.52% |
| 2015 Q1 | 31.64 Million CNY | -26.38% |
| 2014 Q3 | 9.81 Million CNY | -52.31% |
| 2014 Q2 | 20.57 Million CNY | 48.76% |
| 2014 Q1 | 13.82 Million CNY | -62.72% |
| 2014 FY | - CNY | 15.01% |
| 2014 Q4 | 42.98 Million CNY | 338.17% |
| 2013 Q2 | 20.27 Million CNY | 33.36% |
| 2013 FY | - CNY | 23.27% |
| 2013 Q3 | 7.12 Million CNY | -64.86% |
| 2013 Q4 | 37.09 Million CNY | 420.65% |
| 2013 Q1 | 15.2 Million CNY | -33.5% |
| 2012 Q3 | 7.67 Million CNY | -50.71% |
| 2012 Q2 | 15.57 Million CNY | 10.72% |
| 2012 Q4 | 22.86 Million CNY | 197.76% |
| 2012 Q1 | 14.06 Million CNY | -34.75% |
| 2012 FY | - CNY | 23.61% |
| 2011 Q1 | 8.49 Million CNY | 0.0% |
| 2011 Q4 | 21.56 Million CNY | 249.01% |
| 2011 Q3 | 6.17 Million CNY | -52.44% |
| 2011 Q2 | 12.99 Million CNY | 52.96% |
| 2011 FY | - CNY | 24.03% |
| 2010 FY | - CNY | 103.0% |
| 2009 FY | - CNY | 77.52% |
| 2008 FY | - CNY | 0.0% |